North Dakota Clinical Trials Report — March 2026

Critical Deadlines for Advanced Oncology Research

Time is strictly limited for North Dakota residents seeking access to several late-stage oncology research programs. Within the next 90 days, enrollment windows will permanently close for 6 clinical trials across the state. Because none of these closing studies are accepting healthy volunteers, patients currently managing specific cancer diagnoses must act immediately to secure a spot before the final deadlines pass. These closing trials represent critical opportunities for individuals seeking experimental interventions for advanced and complex malignancies. Final participant slots are rapidly filling for studies focused on the following specific conditions:

• Stage IV lung cancer (AJCC v8)
• Anatomic stage II breast cancer (AJCC v8)
• Anatomic stage III breast cancer (AJCC v8)
• Endometrial adenocarcinoma and endometrioid adenocarcinoma
• Endometrial clear cell and mixed cell adenocarcinoma
• Endometrial dedifferentiated and undifferentiated carcinoma
• Endometrial mucinous adenocarcinoma

For patients navigating stage IV lung cancer or advanced anatomic breast cancers, these closing trials often provide access to novel therapeutic combinations or targeted drug delivery systems that are not yet available through standard clinical care. The designation of AJCC v8 indicates that these studies utilize the American Joint Committee on Cancer’s most recent staging criteria, ensuring that experimental treatments are precisely matched to the genetic and anatomical profile of the tumor. Similarly, the wide array of endometrial carcinomas reaching their enrollment caps highlights a concentrated effort by researchers to understand and treat highly specific histological subtypes of uterine cancer. From clear cell to mucinous adenocarcinomas, the granular focus of these trials underscores the shift toward highly personalized oncology. Once these 6 studies close, local access to these specific experimental protocols will end.

Federal Nutrition Research Launches in Grand Forks

March brings a highly specialized research opportunity to the state, driven entirely by federal initiatives rather than commercial pharmaceutical companies. While January saw two new studies open, this month introduces a single, highly focused trial based in Grand Forks. The USDA Grand Forks Human Nutrition Research Center is the sole sponsor of this month's new initiative, reinforcing the facility's role as a premier federal institution dedicated to understanding how diet, agriculture, and metabolic processes impact human health. The presence of a federally sponsored trial provides a distinct alternative to industry-funded research, often focusing on preventive health and lifestyle interventions rather than pharmaceutical therapeutics.

Unlike the oncology trials closing this spring, this newly launched federal study is actively recruiting healthy individuals. Nutrition research relies heavily on participants without underlying chronic conditions to establish baseline metabolic data, test dietary interventions, and understand how nutritional changes affect overall wellness. The trial is open to older adults, ensuring that the aging population of North Dakota is represented in federal health data. Including seniors in nutritional research is vital for developing dietary guidelines that help maintain cognitive function, bone density, and metabolic health as the body ages. Furthermore, the study maintains broad demographic access by not restricting enrollment based on gender, nor does it include pediatric participants.

Statewide Clinical Infrastructure and Volunteer Opportunities

Despite the modest number of new launches this month, North Dakota maintains a robust and highly accessible clinical research infrastructure. Currently, 213 clinical trials are actively recruiting participants across the state. These studies are distributed among 7 different cities, utilizing 88 distinct research sites. This geographic footprint translates to an average of more than twelve research facilities per participating city, indicating a strong network of both major hospital systems and localized community clinics. This spread ensures that residents living outside of the immediate Grand Forks or Fargo metropolitan areas still have viable pathways to access cutting-edge medical research and experimental therapies without undertaking prohibitive travel.

For residents who do not have a specific medical diagnosis but still wish to contribute to scientific advancement, the landscape offers several immediate pathways. With the addition of the new USDA nutrition study, there are now 14 active trials recruiting healthy volunteers statewide. Healthy participants serve as the essential control group for a vast array of scientific inquiries, from pharmacokinetic drug testing to behavioral and dietary interventions. Without these volunteers, researchers cannot accurately measure the efficacy or safety of new medical breakthroughs, making community participation a cornerstone of the medical development process.

Analyzing Regional Enrollment Trends

The pace of new clinical trial launches in North Dakota has demonstrated a distinct wave pattern over the past two seasons. Looking back at the six-month historical data, research activity began modestly in September with a single new trial, followed by a steady escalation through the autumn months. October brought two new studies, November saw three, and the region reached a peak in December with 5 new clinical trials opening their doors. Since the start of the new year, the initiation of new studies has gradually cooled, with two launches in February and just one this March.

This cyclical nature of trial initiation often reflects the broader academic and federal funding calendars, where grant cycles and institutional review board approvals cluster around the end of the calendar year. The current lull in new trial volume makes the existing inventory of actively recruiting studies all the more vital for patients seeking alternative care options. As federal facilities like the USDA Grand Forks Human Nutrition Research Center begin enrolling their spring cohorts, the regional research focus is positioned to expand its emphasis on preventive health, metabolic baselines, and dietary interventions tailored specifically for an aging rural demographic.